PPARG and neoplasm: PPARγ agonists can halt the tumor cell growth cycle of the colorectal cancer, induce the differentiation of intestinal cancer cells, change the morphology of tumor cells, and promote tumor cell apoptosis to achieve the antitumor effect [36].